MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin

Jian-Yong Sun1, Yi Huang, Ji-Peng Li

  • 1State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, 710032 Xi'an, China.

Insights

MicroRNA (miR-320a) is downregulated in colorectal carcinoma, inhibiting cancer cell growth by targeting beta-catenin. This suggests miR-320a

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNA (miRNA) deregulation, specifically miR-320a, is observed in human colorectal carcinoma.
  • The precise role and regulatory mechanisms of miR-320a in colorectal carcinoma development remain unclear.

Purpose of the Study:

  • To investigate the expression pattern of miR-320a in colorectal carcinoma.
  • To elucidate the functional role of miR-320a in colon cancer cell biology.
  • To identify and validate the direct molecular targets of miR-320a in colorectal carcinoma.

Main Methods:

  • Real-time PCR was used to quantify miR-320a expression in colon cancer cell lines and tumor tissues.
  • Gain-of-function experiments were performed to assess the biological impact of miR-320a restoration.
  • Bioinformatic analyses combined with experimental validation were employed to confirm miR-320a target genes.

Main Results:

  • miR-320a expression was found to be significantly downregulated in colon cancer cell lines and tissues.
  • Restoration of miR-320a expression suppressed colon cancer cell proliferation.
  • Beta-catenin was identified as a direct target gene of miR-320a, and a reciprocal relationship was observed between miR-320a and beta-catenin's downstream genes in tumor tissues.

Conclusions:

  • miR-320a acts as a tumor suppressor in colon cancer by directly targeting and inhibiting beta-catenin.
  • The findings suggest miR-320a has potential as a prognostic biomarker and therapeutic target for colorectal carcinoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...